Uh-Oh! Cannabis Stocks Are Imploding

Pot stocks are free-falling. Cronos Group (TSX:CRON)(NASDAQ:CRON) and Aphria Inc. (TSX:APHA)(NYSE:APHA) are two examples.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

If you were among those who invested in cannabis stocks, you may now be worried about another dot-com bubble. Major pot stocks have seen share prices drop in the past several months, contrary to expectations.

You may have expected exponential growth following the legalization of recreational marijuana in Canada, so this may make you worried about the entire industry.

The good news is that this is still no reason to panic and shun pot stocks altogether. First off, growth estimates for legal marijuana are still on track. There is an excellent explanation for this inexplicable trend, but you need to look at some specific companies to see it.

Two great examples to illustrate the state of the cannabis industry are Aphria Inc. (TSX:APHA) (NYSE:APHA) and Cronos Group (TSX:CRON)(NASDAQ:CRON).

Why are pot stocks on the decline?

On April 15, 2019, Aphria announced earnings for the third quarter of fiscal 2019 ended February 28, 2019. In the earnings report, APHA had recorded a net income loss of $108.2 million or $0.43 per share.

The damage was contrary to market expectations of $0.03 gains per share, sending stocks 15% lower from the previous trading day’s closing price of about $13.50 on the TSX.

Positive results then followed these depressing results in the fourth quarter of fiscal 2019 ended May 31, 2019. In this quarter, profit was $15.76 million following a 74% growth in revenue from the third quarter. Although stocks grew significantly by 40% after the news, share prices would still not break above $10.

The story is not much different from that of Cronos, which has experienced a decrease of over 50% in stock price since the beginning of the year. However, unlike Aphria, which enjoyed profits in the fourth quarter, Cronos Group still made operating losses in the second quarter of fiscal 2019 ended June 30, 2019.

What does this mean for pot stocks in general?

The aforementioned Aphria and Cronos are but two examples of the general trend in the marijuana industry. Critics of the industry claim that pot stocks and market growth expectations were too optimistic.

The marijuana industry is expected to reach a valuation of $66.3 billion by 2025 in North America and up to $100 billion worldwide.

Critics couldn’t be further from the truth, however, as over $10 billion was invested in 2018 in North America, with funding through 2019 expected to reach $16 billion.

Public marijuana companies raised $394.1 million in January 2019 alone. This amount is in line with the estimated CAGR of 24.1%, demonstrating that the industry’s growth was not overly optimistic.

To get the real picture of pot stock performance, you would need to look at the past couple of years. Looking at the stock prices from last summer, both APHA and CRON stocks have increased in value.

The recent decrease in stock price can therefore be attributed to volatility in the markets and lack of investor confidence. As for the losses recorded by cannabis companies, these were because of acquisitions by these companies that put a dent in cash flow.

Should you invest?

Looking at price charts of cannabis stocks on the TSX, most of these companies experienced a spike around the start of the calendar year in response to the legalization of marijuana in Canada and the subsequent hype.

Current declines in stock price are thus due to market correction, as these stocks achieve actual valuation. Now is therefore the time to buy pot stocks because of obtaining real valuation, in short, they can only go higher.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »